News|Articles|December 5, 2023
Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics
Staying Ahead with Company Updates and Product Innovations. This article's news is from BiomX, SHEA, and CSL and Arcturus Therapeutics.
Advertisement
Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
Infectious Disease Doctor Discusses Hantavirus Outbreak and Public Health Preparedness, Misinformation, and Emerging Disease Threats
2
PASTEUR Act, NDM-CRE Surge, and the Cost of Inaction: What Infection Preventionists Need to Know About Antibiotic Policy and AMR
3
UV-C as a Critical Second Step in Reducing HAIs: Why Adjunct Disinfection Is a Strategic Investment in High-Risk Health Care Environments
4